Crescita is seeking strategic regional partners to license and distribute its product lines outside of Canada. Business development and collaboration with strategic partners is an important pillar of Crescita’s growth strategy as we continually seek to expand our international reach to further leverage our existing portfolio as well as to add new products and technologies that complement it.
Pliaglis is a prescription topical local anesthetic cream that provides safe and effective local dermal analgesia on intact skin prior to superficial dermatological procedures. Pliaglis consists of a proprietary formulation of the highest FDA approved concentration of lidocaine 7% and tetracaine 7% that utilizes proprietary phase-changing topical cream Peel technology. Pliaglis is currently available for licensing and distribution in several territories. Please contact us at email@example.com for any inquiries.
Clinically proven quality dermatology products that promote healthy skin. Crescita manufactures substantially all its dermocosmetics products in Canada, relying on Research and Innovation to remain at the forefront of the industry with the highest performing products.
Crescita is strategically seeking qualified partners to market its product lines internationally. To be considered as a distribution partner please contact us at firstname.lastname@example.org